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Abstract-The actions of 6-thioguanine (TG) and 6-mercaptopurine (MP) were compared in Chinese 
hamster ovary (CHO) cells. Several differences were noted between these two agents. TG caused a 
greater maximal loss of clonogenicity, leaving about one log fewer survivors than did MP, although the 
cells killed by MP appeared to succumb much more rapidly than those killed by TG. MP-treated 
populations experienced a G, or G,/S arrest which was quickly reversed upon drug removal. while TG- 
treated cells were arrested in late S/G,, after some delay. Although TG induced a gross chromosome 
deformation [unilateral chromatid damage, as described earlier in Maybaum and Mandel. Cancer Re.s. 
43,3852 (1983)] MP caused little or no such deformation. Addition of 4-amino-5-imidazolecarboxamide 
(AIC) to MP treatments antagonized MP-induced loss of clonogenicity, while AIC caused a dose- 
dependent potentiation of TG-induced loss of clonogenicity. The interaction between TG and AIC does 
not seem to represent an increase in either purine starvation or incorporation of TG into DNA, 
suggesting that a third mechanism is involved. We suggest that this additional mechanism may possibly 
be related to the induction of differentiation by TG that has been reported in other systems. 
In general, MPI/ and TG behave similarly in most 
biological systems examined, although TG is usually 
more potent than MP [l]. The antitumor spectra of 
the two drugs are almost indistinguishable, and cells 
resistant to one drug are usually cross-resistant to 
the other. No major differences in toxicity in either 
higher animals or humans have been recognized, 
although differences in disposition of the thiopurines 
may account for occasional selective organ toxicity. 
Both thiopurines rely on hypoxanthine-guanine 
phosphoribosyl transferase for conversion to their 
mononucleotides, which are required for phar- 
macological activity, and thereafter both analogs 
follow the pathways for IMP and GMP respectively. 
Also, both thiopurines prevent accumulation of N- 
formyl glycinamide ribonucleotide and de ~OUO 
purine synthesis [2.3] and interfere with purine inter- 
conversion [4-6]. 
There are, however, some differences between 
the drugs which may be more than quantitative. 
Combination of MP and TG prolonged survival time 
markedly beyond that produced by any dose of either 
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/I Abbreviations: MP. h-mercaptoDurine; TG. 6-thio- 
guanine: CHO, Chinese hamster b&y; UCD, unilateral 
chromatid damage; PCC, prematurely condensed chro- 
mosome; HPLC, high performance liquid chromatogra- 
phy; AIC, 4-amin&SIimidazolecarboxamide; MMFR, 
6-methylmercaptopurine ribonucleoside; and PRPP, 
5-phosphoribosylpyrophosphate. 
drug alone, suggesting that the two drugs exert their 
antitumor effects by different mechanisms [7]. Both 
MP and TG form S-methylated derivatives. such as 
6-methylthioinosinic acid and 6-methylthioguanylic 
acid, respectively but, in contrast to the methylated 
MP derivative, that for TG does not contribute sig- 
nificantly to the drug’s inhibition of de nom purine 
synthesis [3]. 
While most evidence indicates that TG cytotoxicity 
in vitro is a result of its incorporation into DNA 
[8,9], the basis of MP cytotoxicity is less clear, as 
both nucleic acid incorporation and purine dep- 
rivation have been implicated in the action of that 
drug [9]. We have demonstrated recently that in the 
CHO cell line TG induces a specific chromosome 
deformation (unilateral chromatid damage. UCD) 
and that the appearance of this damage is closely 
associated with TG-induced cytotoxicity [ 10. 1 l] 
The present work was undertaken to determine if MP 
also induces UCD and, more generally, to ascertain 
whether the cytotoxic actions of TG and MP in CHO 
cells are mediated through common mechanisms. 
MATERIALS AND METHODS 
Wild type CHO cells (a gift from Mary Ann 
Wormstead, University of California. San Francisco) 
were grown as monolayers in alpha minimum essen- 
tial medium (GIBCO, Grand Island, NY) sup- 
plemented with 10% calf serum (GIBCO) and 5% 
fetal calf serum (Biofluids Inc.. Rockville, MD) in a 
humidified 5% CO1 atmosphere. at 37”. Thioguanine 
was recrystallized from boiling water and stored in 
the dark. Procedures for determination of colon> 
forming ability, flow cytometry. and induction of 
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premature chromosome condensation have been 
described recently [ll]. This reference also illustrates 
the scheme used for assigning deformation scores to 
G,-PCCS. 
Experiments in which dye-excluding ability was 
determined were designed to encompass all cells in 
the flask, including those which had detached from 
the monolayer. Drugs were added at t = 0 and cells 
were washed and given fresh. drug-free medium at 
t = 16 hr. At the indicated times, flasks were scraped 
to suspend attached cells and this suspension was 
then centrifuged. After decanting the supernatant 
fraction, a few drop5 of trypan blue solution (0.4V 
in 0.0% NaCI) were added to the cell button for 
2 min. at which time the cells were assayed for dye 
exclusion with a hemocytometer. 
For determination of endogenous nucleotide pools 
the following procedure was used. Cells were treated 
with drug for 3 hr. colllected by scraping, washed 
once with 0.9% NaCl-0.1 M phosphate buffer. 
pH 7.3. and lysed by addition of 2504 of 0.4N 
HClO,. After removing acid-precipitable material 
by centrifugation. the extract was neutralized with 
tri-N-octylamine/freon [ 121 and analyzed by HPLC. 
A portion of the extract was injected onto a 10 [lrn 
Altex strong anion exchange column and eluted iso- 
cratically with 0.4 M NaH2P04. pH 3.6, at 3 ml/min. 
Peaks were detected by U.V. absorbance at 254nm 
and quantified by integration. 
Incorporation of TG into DNA was quantitated 
either by the HPLC procedure of Tidd and Dedhar 
(131 or by measurement of absorbance at 350 nm of 
a solution of purified DNA isolated from TG-treated 
cells [14]. In the cases where both of these methods 
were applied to replicate samples, we obtained 
equivalent results. The intracellular content of acid- 
soluble TG-containing molecules was measured as 
described by Ishiguro and Sartorelli [ 151. 
RESULTS 
To define appropriate conditions for comparison 
of TG and MP. we determined the loss of colony 
forming ability caused by exposure to various con- 
centrations of the drugs for 16 hr (Fig. 1). Sixteen 
hours was chosen as the length of drug treatment so 
that all cells in an asynchronous population would 
be able to undergo one round of DNA synthesis in 
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the presence of the drug. and also to be consistent 
with our previous studies on TG cytotoxicity [ 10. 1 I]. 
As Fig. 1 shows. TG can produce up to 98-99’1 cell 
kill. with 1 PM being the minimum concentration 
needed to reach this level. MP was considerably less 
cytotoxic. with 6&X0% cell kill being the maximum 
effect observed using concentrations up to 500 :&I. 
In most experiments, 50 ILM MP caused a near-maxi- 
mal loss of clonogenicitl;. and this concentration was 
therefore defined as being comparable. though not 
equitoxic. to 4 rtM TG (i.e. the minimum don 
needed to achieve maximal cell kill). In some ca\es, 
50 LIM MP was also compared to 0.4 ELM TG. since 
these concentrations each reduce cloning efficiency 
by about 5OR 
The rapidity with ahich thiopurine-treated cells 
lost membrane integrity was assayed by trypan-blue 
exclusion (Fig. 2). Cells exposed to 4, !yM TG for 
16 hr had no loss of dye-excluding ablhty through 
the tirst 64 hr of the experiment. On the other hand, 
about 50% of those given 50 JIM MP failed to exclude 
dye at t = 40 hr. 
The rapid loss of dye excluding abilit? caused b) 
MP made analysis of chromosome detormation a 
difficult task. since the process of cell fusion is sen- 
sitive to the membrane integrity of the cells involved. 
Therefore. it is likely that those cells which did fur 
would hc from the portion of the population which 
1J 
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Fig. 3. Specific chromosome deformation (unilateral chro- 
matid damage) caused by thiopurines. CHO cells were 
treated with drug for 16 hr followed by 2%hr incubation in 
drug-free medium. at which time premature chromosome 
condensation was induced. Deformation scores were 
assigned as in Rel. 11. One of duplicate experiments having 
similar results is shown for each treatment. N = number of 
G, Pc’Cs scored for each treatment group. 
excluded dye at t = 40 hr. Figure 3 shows that PCCs 
formed from the MP-treated group had only a minor 
degree of deformation present, if at all. This is con- 
sistent with the idea that these ceils represent the 
surviving half of the population. The induction of 
deformation by TG is much more severe and has 
been discussed in detail previously f 1 I]. 
Effects of MP and TG on cell cycle progression 
were determined bv Row cytometry (Fig. 4). The two 
drugs behaved dissimilarly, with TG causing little or 
no inhibiti of progression until 16-20 hr. at which 
time the accumulation of cells with a late S or G: 
content of cells could be observed. MP treatment 
induced a pileup of cells in G , or G i/early S which 
was detectable at 8 hr and was pronounced at 16 hr. 
Upon removal of the drug at t = 16 hr the population 
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Fig. 4. Cell cycle kinetics (as revealed by flow c~totnetr~) 
of CHO cells exposed to 4 FM TG or 50 1frM MP Ior I6 hr. 
at which time drug was removed, cells were washed, and the 
incubation was continued in drug-free medium. Number of 
hours elapsed since beginning of drug exposure is indicated 
in each box. 
The role of purine st~~rvation in mediating TG- 
and MP-induced effects was probed by the addition 
of AIC to drug treatments. Loss of viability caused 
by MP was partially prevented by 200 FM AIC and 
ATP GTP 
Fig. 5. Changes in intracellular ribonucleoside triphosphates induced by 3 hr of treatment with 40 PM 
TG or 50 ,uM MP, 2 AIC. Key: (0) thiopurine alone; (0) thiopurine + 200 PM AIC; and (I) thiopurine 
+ SOO~LM AIC. Dotted line represents control levels. Each value is the mean of three experiments 
-f S.D. 
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Table 1. Effects of AIC on thiopurine-induced loss of 
clonogenicity* 
Colony forming ability (% control) 
Concn AIC (uM) 
Treatment k1 0 200 500 
TG 0 100 101 10s 
4 1.4 t 0.1 0.9 k 0.1 >so 
10 2.6 2 0.1 0.5 2 0.1 >so 
40 3.6 ?_ 0.9 0.3 2 0.1 4.2 f 0.8 
MP 50 45 t 4 59 + 4 95 + 7 
200 37 k 1 76 + 4 88 r 4 
* Cells were treated concurrently with AIC and TG or 
MP for 16 hr, as for Fig. 1. 
more completely prevented by SOOpM AIC 
(Table 1). No conditions were found by which AIC 
potentiated cell kill by MP. In contrast, the effect of 
AIC on TG-induced cell kill was dose dependent. 
Over the range of TG concentrations shown, 200 PM 
AIC potentiated loss of viability while 500 PM AIC 
was protective. At slightly lower TG concentrations 
(0.4 to 1.0 PM), 200 PM AIC partially prevented cell 
kill (data not shown). 
Effects of AIC on TG metabolism are given in 
Table 2. Addition of 200pM AIC to either 4 or 
40 PM TG resulted in diminished incorporation of 
the drug into DNA, an effect which was more pro- 
nounced at 500 PM AIC. The intracellular content 
of TG-containing, acid-soluble species was also 
reduced by 200 ,uM AIC, roughly in parallel with the 
incorporation data. 
Changes in pyrimidine ribonucleotide pools 
caused by MP and TG were virtually identical 
(Fig. 5). Each drug apparently induced elevations 
of UTP and CTP which were negated by either 
concentration of AIC, although there was con- 
siderable variation in the values obtained. Purine 
ribonucleotides responded somewhat differently to 
the two drugs. The concentration of ATP was not 
changed by either drug alone, nor by MP plus 200 PM 
AIC, while TG plus either concentration of AIC 
produced an expanded ATP pool. The concentration 
of GTP was depressed severely by MP but not 
changed by TG. Addition of AIC to either drug 
increased GTP levels in a dose-dependent manner. 
DISCUSSION 
Although the thiopurines TG and MP are among 
the most extensively studied chemotherapeutic 
agents known. it has not been possible to consistently 
assign a single mechanism of cytotoxicity to them. 
This is due in large part to the fact that, like many 
other agents. MP and TG can produce multiple 
biochemical lesions which are interactive and there- 
fore difficult to study individually. Each of the actions 
of thiopurines (inhibition of de nova purine biosyn- 
thesis. inhibition of purine nucleotide intercon- 
version and incorporation of TG into nucleic acids) 
has been proposed as contributing to thiopurine cyto- 
toxicity, and it is clear that modulation of one of 
them may affect the others. For instance, inhibiting 
purine synthesis may enhance incorporation of thio- 
purines by lowering the pool of a competing natural 
purine nucleotide. On the other hand, inhibition of 
IMP dehydrogenase might decrease the conversion 
of 6-thio-IMP to 6-thio-GMP and therefore attenuate 
incorporation of TG nucleotides into nucleic acids. 
In addition to this multiplicity of biochemical 
actions. it has also been shown that in some cases 
thiopurine cytotoxicity may be manifested either in a 
delayed manner or immediately upon drug exposure 
116. 17). This raises the possibility that the major 
cytotoxic mechanism of either MP or TG may vary 
with conditions of drug exposure, or from one cell 
line to another. and that under some circumstances 
the two drugs might kill cells by different mechanisms 
[18]. For example. in L5178Y cells treated with MP, 
inhibition of thiopurine incorporation into DNA fol- 
lowing treatment with high-dose thymidine [lS] or 
mycophenolic acid 181. which inhibit DNA synthesis, 
reduces the cytotoxic action of MP. Furthermore, 
in this cell line. the similar extents of thiopurine 
incorporation into DNA resulting from equitoxic 
treatments with TG and MP [18] indicate that both 
drugs act by interfering with DNA synthesis. In 
contrast, in CHO cells there is relatively little DNA 
incorporation of MP compared to TG. and these 
cells are not protected from MP toxicity by DNA 
synthesis inhibitors [IX]. Thus. in CHO cells the 
mechanisms of cytotoxicity of these agents are dif- 
ferent. Since we have shown recently that the delayed 
cytotoxicity of TG in CHO cells is strongly associated 
with a specific and unique chromosome deformation 
(UCD) [ I1 1. we wished to determine whether this 
Table 2. Effects of AIC on TG metabolism in CHO cells’ 
T<;-containing molecule\ 
TG incorporatlon into DNA in acid-soluble fraction 
(‘% replacement of G by TG) ( pmoles/lOh cell5) 
AIC W) AlC (/IM) 
0 200 SO0 0 200 
4,uMTG 1.5 (0.2) 0.27 (0.11) 0.05 (0.05) 331 f 26 64 _c 12 
40 /LM TG 1.3 f 0.4 0.41 ? 0.22 0.09 i- 0.01 576 -c 45 x7 2 2 
* Exponentially growing CHO cells were exposed to TG with or without AIC tar 16 hr. 
at which time cells were harvested and analyzed for TG incorporation into DNA or. in 
separate experiments, total intracellular TG-containing, acid-soluble compounds. Data 
shown represent either the mean of duplicate experiments followed by the range of the two 
observations (in parentheses) or the mean of triplicate observations i S.D. 
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deformation is also produced by MP in this line and 
whether it plays a role in MP-induced cytotoxicity. 
Our first objective was to define appropriate treat- 
ment conditions under which to compare the two 
drugs. In preliminary expariments it became appar- 
ent that there was a difference of about one log in 
the maximal cell kill achievable by 16-hr exposure 
of CHO cells to the thiopurines, with TG-treated 
populations maintaining about l-2% survivors ver- 
sus 2&30% for MP (Fig. 1). Tidd and Paterson [S] 
previously made a similar observation in L5178Y 
cells, although the absolute levels of cell kill in their 
study were much higher than those seen here. Para- 
doxically, there was a slight, but significant, decrease 
in TG-induced cytotoxicity as the drug concentration 
exceeded 4 PM. This effect has been noted previously 
[19,20] and may be due to antagonism of DNA 
synthesis (and therefore thiopurine incorporation 
into DNA) by purine starvation [19]. 
To determine whether the toxicities of MP and 
TG were immediate or delayed effects, we examined 
the dye excluding ability of TG- or MP-treated cells. 
Figure 2 indicates a major discrepancy in the actions 
of MP and TG on the ability of cells to exclude 
trypan blue. Whereas the population exposed to TG 
had few long-term survivors, there was no detectable 
loss of dye exclusion through the first 64 hr of the 
experiment. In contrast, the MP-treated population 
had about 50% of its cells failing to exclude dye 
within 4@-60 hr, which corresponds closely to the 
total loss of clonogenicity caused by this treatment. 
Although trypan blue exclusion is not a reliable 
indicator of long-term survival, it is reasonable to 
assume that those cells which fail to exclude dye are 
not viable, and therefore we conclude that the great 
majority of MP-induced cytotoxicity in this situation 
is through a relatively immediate process. 
Previous studies have shown that delayed MP cyto- 
toxicity is related to drug incorporation into nucleic 
acids [8,9], and is not due to purine nucleotide 
depletion [21]. However, it is also known that 
MMPR, when anabolized to the nucleotide level, 
can induce cell death [22] and this agent is thought 
to act solely by purine synthesis inhibition. It is 
therefore possible that in the present case 50 PM 
MP kills cells by purine nucleotide depletion. Flow 
cytometric analysis illustrates that MP (50 uM, LL)~,,) 
had a qualitatively different effect on cell cycle pro- 
gression than did TG (4 PM, LDg8) (Fig. 4). The G, 
or G 1/s accumulation shown to occur following MP 
treatment would be expected of cells whose DNA 
synthesis was inhibited, as is the progression of a 
wave of cells into S-phase upon relief of the block 
by drug removal (Fig. 4, t = 20 hr). 
To further examine the role of purine synthesis 
inhibition, we measured the effect on clonogenicity 
of adding AIC to MP or TG treatments. Since amino- 
imidazole carboxamide-5’-phosphate (formed from 
AIC and PRPP) occurs in the de nouo purine path- 
way after the steps inhibited by thiopurines, AIC 
has classically been used to circumvent thiopurine- 
induced purine synthesis inhibition [23]. The results 
in Table 1 illustrate that nearly complete protection 
from MP cytotoxicity could be attained by co-incu- 
bation with 500pM AIC. This protection is con- 
sistent with previous data [9. IS] and parallels the 
elevation of GTP to control levels (Fig. 5), further 
suggesting a role for purine synthesis inhibition in 
MP cytotoxicity. On the other hand, the effects of 
AIC on TG cytotoxicity depend on the con- 
centrations of both TG and AIC. From the data in 
Fig. 5 it is clear that TG has little or no effect on 
purine pools although an elevation of pyrimidine 
pools occurred, indicating that some perturbation of 
nucleotide or nucleic acid metabolism had taken 
place. When 200 PM AIC was present, all four ribo- 
nucleoside triphosphates were at or near control 
levels, suggesting that the metabolic disturbances 
caused by 40 uM TG had been relieved. Since this 
change was accompanied by increased cell kill, we 
speculated that the combination of 40 PM TG and 
200pM AIC might permit some fraction of cells to 
synthesize DNA (and therefore incorporate TG) 
more efficiently than in the presence of 40 /tM TG 
alone. Also, since AIC inhibits guanase [24], the 
addition of this compound might antagonize cata- 
bolism of TG, resulting in greater anabolism of the 
drug. The results in Table 2 contradict these hypoth- 
eses, however, as they demonstrate that both the 
incorporation of TG into DNA and the accumulation 
of acid-soluble intracellular TG derivatives were 
antagonized by 200,uM AIC. These data suggest 
that the loss of clonogenicity resulting from adding 
200 FM AIC to 40 PM TG is not easily attributable 
to either of the mechanisms that have traditionally 
been implicated in thiopurine action (i.e. purine 
starvation or DNA incorporation). A third possi- 
bility is suggested by recent reports that TG can 
induce differentiation in HL60 cells and that this 
effect can be amplified by concurrent treatment with 
various nucleosides [ 15,25,26]. We are continuing 
to study the interaction between AIC and TG in 
CHO cells in order to discern whether differen- 
tiation or some related phenomenon may be re- 
sponsible for the synergistic loss of clonogenicity 
observed here. 
In summary, the data presented here are consistent 
with previous observations that in CHO cells the 
cytotoxic mechanisms of TG and MP are different. 
We have provided additional evidence that in this 
cell line MP caused a rapidly reversible G1 or G1/S 
block (consistent with nucleotide deprivation). that 
MP did not induce the unilateral chromatid damage 
associated with TG incorporation into DNA, and 
that cytotoxicity caused by MP was manifested in an 
immediate, rather than a delayed manner. These 
properties are in contrast to the cytotoxicity induced 
in CHO cells by TG. which has been shown pre- 
viously to be associated with delayed Gz arrest and 
unilateral chromatid damage, probably resulting 
from incorporation of the drug into DNA. Fur- 
thermore, we have described a novel synergism 
between TG and the purine precursor AIC which 
cannot be explained on the basis of either purine 
depletion or DNA incorporation, and which we sug- 
gest may be related to the TG-induced differentiation 
described by other investigators. This effect, which 
is dependent on the concentration of both TG and 
AIC, may have therapeutic utility if it can be shown 
that there is a sufficient difference between the con- 
centrations of AIC needed to potentiate TG action 
in tumor versus host tissue. 
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